AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 290: L738-L746, 2006. First published November 4, 2005; doi:10.1152/ajplung.00280.2005
1040-0605/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/L738    most recent
00280.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, J.
Right arrow Articles by Wilson, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, J.
Right arrow Articles by Wilson, M. A.

Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation

Jie Fan,1,2 Yuehua Li,1 Yoram Vodovotz,1 Timothy R. Billiar,1 and Mark A. Wilson1,2

1Department of Surgery, School of Medicine, University of Pittsburgh, and 2Surgical Research, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania

Submitted 29 June 2005 ; accepted in final form 1 November 2005


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Hemorrhagic shock renders patients susceptible to the development of acute lung injury in response to a second inflammatory stimulus by as yet unclear mechanisms. We investigated the role of neutrophils (PMN) in alveolar macrophage (AM{phi}) priming, specifically, the role in mediating Toll-like receptor (TLR)4 and TLR2 cross talk in AM{phi}. Using a mouse model of hemorrhagic shock followed by intratracheal administration of LPS, we explored a novel function of shock-activated PMN in the mechanism of TLR2 upregulation induced by LPS-TLR4 signaling in AM{phi}. We showed that antecedent hemorrhagic shock enhanced LPS-induced TLR2 upregulation in AM{phi}. In neutropenic mice subjected to shock, the LPS-induced TLR2 expression was significantly reduced, and the response was restored upon repletion with PMN obtained from shock-resuscitated mice but not by PMN from sham-operated mice. These findings were recapitulated in mouse AM{phi} cocultured with PMN. The enhanced TLR2 upregulation in AM{phi} augmented the expression of macrophage inflammatory protein-2, TNF-{alpha}, and macrophage migration inhibitory factor in the AM{phi} in response to sequential challenges of LPS and peptidoglycan, a prototypical TLR2 ligand, which physiologically associated with amplified AM{phi}-induced PMN migration into air pouch and lung alveoli. Thus TLR2 expression in AM{phi}, signaled by TLR4 and regulated by shock-activated PMN, is an important positive-feedback mechanism responsible for shock-primed PMN infiltration into the lung after primary PMN sequestration.

acute lung injury; lipopolysaccharide; innate immunity; peptidoglycan; Toll-like receptor

THE DEVELOPMENT OF ACUTE LUNG INJURY and acute respiratory distress syndrome in individuals following major trauma contributes significantly to morbidity and mortality in this patient population (2, 18). Studies have suggested that the global ischemia-reperfusion related to resuscitation from hemorrhagic shock promotes the development of lung injury by priming the innate immunity for an exaggerated inflammatory response to a second, often trivial, inflammatory stimulus, the so-called "two-hit" hypothesis (27). Using a rodent model of hemorrhage/resuscitation, we previously demonstrated that an antecedent shock leads to augmented lung neutrophil (PMN) sequestration and lung injury in response to a small dose of intratracheal lipopolysaccharide (LPS) (14). This effect appeared to be mediated by the increased LPS-stimulated release from alveolar macrophages (AM{phi}) of proinflammatory cytokines and chemokines, including TNF-{alpha} and cytokine-induced neutrophil chemoattractant (CINC) (12, 14). These findings suggest a hemorrhagic shock-primed cellular responsiveness to pathogenic product.

Macrophage activation in response to microbial infection depends on Toll-like receptors (TLRs), a family of pattern recognition receptors and key regulators of both innate and adaptive immunity (23). To date, 13 mammalian TLR paralogs have been identified (10 in humans and 12 in mice) (3). TLR2 is crucial for the propagation of the inflammatory response to components of gram-positive and gram-negative bacteria and mycobacteria such as peptidoglycan (PGN), lipoteichoic acid (LTA), bacterial lipoproteins, lipopeptides, and lipoarabinomannan (19, 22, 34, 36). TLR2 is predominantly expressed in cells involved in the first line of host defense, including monocytes, macrophages, dendritic cells, and PMN (17, 29, 37, 38). TLR4 has been identified as the receptor for LPS and LTA (20, 26). Recently, we reported that TLR4 signaling upregulates TLR2 in LPS-stimulated endothelial cells, and thus the cells' response to TLR2 ligands is significantly amplified (10). These results raised the possibility of a mechanism of inducible cell sensitivity to infection. These observations led us to further investigate the role of TLR4-TLR2 cross talk in AM{phi} priming in the setting of hemorrhage/resuscitation.

In the present study, using both in vivo hemorrhage/resuscitation mouse model and in vitro PMN-AM{phi} coculture approaches, we demonstrated that the TLR4-dependent TLR2 upregulation in AM{phi} is significantly augmented by antecedent shock, and this effect of shock is particularly mediated by shock-activated PMN. The functional relevance of the amplified TLR4-induced TLR2 expression in AM{phi} was evident by a markedly increased expression of chemokine macrophage inflammatory protein-2 (MIP-2), cytokine migration inhibitory factor (MIF), and TNF-{alpha} in the AM{phi} as well as induction of augmented PMN migration in response to sequential challenges of LPS and PGN. Thus, TLR2 expression in AM{phi}, signaled by TLR4 and regulated by hemorrhagic shock-activated PMN, could be an important positive-feedback mechanism responsible for shock-primed AM{phi} activation and alveolar neutrophilia following primary PMN sequestration.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Hemorrhagic shock and lung injury. Male C57BL/6 wild-type (WT) mice and C3H/HeJ mice were purchased from the Jackson Laboratory; TLR2–/– mice were obtained from Dr. Shizuo Akira (Research Institute for Microbial Diseases, Osaka Univ., Osaka, Japan) (35). All experimental protocols involving animals were approved by the Institutional Animal Care and Use Committee of Veterans Affairs Pittsburgh Healthcare System. Mice were 9–10 wk of age at the time of experiments. Animals were anesthetized with 50 mg/kg ketamine and 5 mg/kg xylazine administered intraperitoneally. Femoral arteries were cannulated for monitoring of mean arterial pressure (MAP), blood withdrawal, and resuscitation. Hemorrhagic shock was initiated by blood withdrawal and reduction of the MAP to 40 mmHg within 15 min. Blood was collected into a 1-ml syringe and heparinized to prevent clotting. After a hypotensive period of 60 min, animals were resuscitated by transfusion of the shed blood and Ringer's lactate in a volume equal to that of the shed blood, over a period of 30 min. The catheters were then removed, the femoral artery was ligated, and the incisions were closed. Sham animals underwent the same surgical procedures without hemorrhage and resuscitation. Animals then underwent a tracheotomy using a 20-gauge catheter 1 h after the end of resuscitation (or sham) and received either repurified LPS [Escherichia coli O111:B4; Sigma, St. Louis, MO; LPS repurification was carried out as previously described (19a)] or 30 µg/kg in 50 µl of saline (SAL) or SAL alone intratracheally. The experimental protocol was described as having animals in one of four groups: sham/SAL, shock/SAL, sham/LPS, and shock/LPS. Using this protocol, we previously showed that animals subjected to shock/LPS exhibited increased lung permeability and PMN counts in bronchoalveolar lavage (BAL) fluid compared with all other groups, whereas the sham/LPS group had a small increase in BAL PMN count but no change in permeability (14). At various time points after LPS or SAL administration, AM{phi} were recovered from BAL fluid for TLR2 detection by RT-PCR and Western blotting.

In vivo PMN depletion and repletion. PMN depletion was induced using RB6–8C5 monoclonal antibody (Ly-6G/Gr-1 specific; eBioscience, San Diego, CA) (1, 15) as previously described (10).

PMN repletion in neutropenic mice was performed by tail vein injection of PMN (~2 x 106 cells) isolated from mouse blood. The immunomagnetic separation system (BD Biosciences Pharmingen, San Diego, CA) (8) was used to isolate PMN. Viability of the isolated PMN was >95%, and PMN population was >95% as assessed by trypan blue exclusion (4) and Wright-Giemsa staining, respectively.

AM{phi} isolation. BAL was performed as previously described (14). Normally, the BAL fluid contains ~91% of AM{phi} and ~9% of other cells, including PMN, lymphocytes, and erythrocytes. The immunomagnetic separation system as described above was used to isolate AM{phi} from BAL fluid. Magnetic nanoparticle-conjugated antibodies (anti-mouse Gr-1, anti-CD4, anti-CD8, and anti-CD45R/B220 antibodies; BD Biosciences) were chosen to label and remove PMN and lymphocytes. The resulting cells consisted of >98% macrophages, and cell viability was >95%.

PMN-AM{phi} coincubation and air pouch PMN migration assay. PMN-AM{phi} coincubation was performed using Transwell. Peripheral PMN were isolated from the mice subjected to either hemorrhage/resuscitation or sham operation, and the AM{phi} were recovered from BAL fluid using the methodology as described above. The coculture was then stimulated with repurified LPS (1 µg/ml) for 2–8 h in DMEM containing 10% FCS at a concentration of 1 x 106 cells/ml of medium. In some experiments, we first stimulated the cocultures with repurified LPS for 2 h, removed PMN and added PGN (1 µg/ml; Staphylococcus aureus, Sigma), and continued incubation for another 2 h. MIP-2, MIF, and TNF-{alpha} expression in the AM{phi} lysates was measured by Western blotting. In some experiments, the AM{phi}, which were preincubated with shock-activated PMN and sequentially treated with LPS and PGN (as described above), were collected from the Transwell, resuspended in Ringer's lactate in a concentration of 1 x 106 cells/ml, and injected into a mouse air pouch to induce PMN migration.

A mouse air pouch was prepared as described (9). To perform the PMN migration assay, the pretreated AM{phi}, as described above, were injected into the air pouch serving as a chemoattractant resource. Air pouch lavage fluid was then collected for PMN counts at 4 h after the injection of the macrophages.

RT-PCR. Total RNA from AM{phi} was isolated using TRI-REAGENT (Molecular Research Center, Cincinnati, OH) following the manufacturer's instructions. Total RNA was then reverse transcribed using a SuperScript Preamplification kit (Invitrogen, Carlsbad, CA). Primers for TLR2 amplification were: position 1008 forward 5'-ATACTAACTTGGCCAGGTTC-3', position 1590 reverse 5'-AAAGTGTTCCTGCTGATGTC-3', amplifying 582 bp. Primers for mouse GAPDH were purchased from R&D Systems (Minneapolis, MN). The product of reverse transcription was amplified following the kit's instructions. PCR products were separated using 1.2% agarose gel and identified by ethidium bromide staining. Expression of mRNA was quantitated using Scion Image software (Scion, Frederick, MD) and normalized by the GAPDH signal.

Western blot analysis. Aliquots of AM{phi} lysates were separated on a 10% SDS-PAGE under nonreducing conditions. Equivalent loading of the gel was determined by quantitation of protein as well as by reprobing membranes for actin detection. Separated proteins were electroblotted onto polyvinylidene difluoride membranes and blocked for 1 h at room temperature with Tris-buffered saline containing 1% BSA. The membranes were then probed with primary antibody (polyclonal anti-TLR2, -MIP-2, -MIF, or -TNF-{alpha} antibody purchased from Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature for 1 h. After being washed, primary antibodies associated with the membranes were detected on autoradiographic film by horseradish peroxidase-conjugated secondary antibodies and the ECL plus chemiluminescent system (Amersham, Arlington Heights, IL) according to the manufacturer's instructions. Blots were quantitated using Scion Image software and normalized by actin signal.

Statistics. The data are presented as means ± SE of n determinations as indicated in the figures. Data were analyzed by one-way analysis of variance; post hoc testing was performed using the Bonferroni modification of the t-test. Where individual studies are demonstrated, these are representative of at least three independent studies.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
LPS upregulates TLR2 expression in AM{phi} through TLR4 signaling. As shown in Fig. 1A, LPS challenge of AM{phi}, which were isolated from the BAL fluid of WT mice, was associated with an increased TLR2 mRNA expression at 1 h and more marked increases at 2 and 6 h. The increased TLR2 mRNA trended back to basal level 16 h after LPS stimulation. However, in AM{phi} derived from C3H/HeJ mice, which are not responsive to LPS because of a point mutation of TLR4 affecting the Toll/IL-1 receptor domain (32, 33), LPS failed to induce TLR2 expression (Fig. 1A). This result suggests that TLR4 signaling mediates the LPS-induced upregulation of TLR2. The changes in protein expression of TLR2 shown in Fig. 1B paralleled the changes in mRNA.


Figure 1
View larger version (24K):
[in this window]
[in a new window]
  		Fig. 1. LPS upregulates Toll-like receptor (TLR)2 expression in alveolar macrophages (AM{phi}) through TLR4 and NF-{kappa}B signaling. A and B: mouse AM{phi} were collected from wild-type (WT) mice bronchoalveolar lavage (BAL) fluid and stimulated with repurified LPS (1 µg/ml) in DMEM containing 10% FCS at a concentration of 1 x 106 cells/ml of medium for 0–16 h. The images are representative of 3 independent studies. The graphs depict means and SE from 3 mice. A: RT-PCR for TLR2 mRNA expression in the AM{phi}. GAPDH mRNA was detected for normalizing the densitometry of TLR2 mRNA. B: Western blot for TLR2 protein in the AM{phi}. Corresponding actin was identified for normalizing the densitometry of TLR2. C and D: AM{phi} were treated with LPS (1 µg/ml) in the presence or absence of the NF-{kappa}B inhibitor IKK-NBD (100 µM) for 2 h, followed by detection of TLR2 mRNA using RT-PCR (C) and TLR2 protein using Western blot (D). Data are representative of 3 independent studies.

 
The promoter region of the TLR2 gene contains two NF-{kappa}B consensus binding sequences believed to regulate gene transcription (28). To address the role of NF-{kappa}B in mediating LPS-induced upregulation of TLR2 in AM{phi}, we assessed the effects of IKK-NBD, an NF-{kappa}B inhibitor (6), on the LPS-induced TLR2 expression in AM{phi}. As shown in Fig. 1, C and D, the NF-{kappa}B inhibitor (100 µM) partially but significantly attenuated the LPS-induced upregulation of TLR2 expression in WT AM{phi} at 2 h after LPS challenge (Fig. 1, C and D). This result demonstrates a role for NF-{kappa}B signaling in mediating TLR4-TLR2 cross talk.

Hemorrhage/resuscitation enhances LPS-induced TLR2 upregulation in AM{phi}. To address the role of antecedent hemorrhagic shock in the regulation of TLR2 in AM{phi}, animals were subjected to hemorrhage/resuscitation (shock) or sham operation and then given LPS or SAL intratracheally at 1 h after resuscitation. AM{phi} were then recovered from BAL fluid at 1–4 h after LPS or SAL for TLR2 mRNA detection. As shown in Fig. 2A, AM{phi} from sham animals demonstrated a low level of TLR2 mRNA expression. Shock alone induced a slight increase in TLR2 in AM{phi} by 4 h. Administration of LPS to sham animals resulted in an increase in TLR2 mRNA in AM{phi} by 2 h, which increased further by 4 h. However, animals subjected to shock before LPS exhibited a marked increase in TLR2 mRNA by 2 and 4 h (1.6- and 2.3-fold increase vs. sham/LPS, respectively). Considered together, these data support the notion of a priming role for hemorrhagic shock in the LPS-induced TLR2 upregulation in AM{phi}.


Figure 2
View larger version (29K):
[in this window]
[in a new window]
  		Fig. 2. Effect of hemorrhagic shock on LPS-induced TLR2 upregulation in AM{phi}. A: WT animals were subjected to hemorrhage-resuscitation or sham operation followed by repurified LPS (30 µg/kg) or saline (SAL) intratracheally. AM{phi} were recovered 1, 2, and 4 h after LPS or SAL, and TLR2 mRNA expression in the AM{phi} was detected by RT-PCR. The graph depicts means and SE of densitometry of TLR2 mRNA, which normalized by corresponding GAPDH mRNA density, from 3 mice. **P < 0.01 compared with all other groups; *P < 0.01 compared with the groups labeled with no asterisk. B and C: WT and C3H/HeJ (C3H) mice were subjected to hemorrhage-resuscitation or sham operation and followed by intratracheal LPS or SAL as described in A. AM{phi} were recovered 4 h after LPS or SAL, TLR2 mRNA in the AM{phi} was detected by RT-PCR (B), and the protein level was analyzed by Western blot (C). Images are representative of 3 independent studies. The graphs show means and SE of densitometry of TLR2 mRNA and TLR2 protein, respectively, from 3 mice. *P < 0.05 compared with other groups; **P < 0.01 compared with other groups.

 
To address the role of TLR4 signaling in shock-modulated TLR2 expression, C3H/HeJ mice were subjected to shock followed by intratracheal LPS. By 4 h after LPS administration, LPS failed to upregulate TLR2 mRNA and protein expression in the AM{phi} derived from C3H/HeJ mice (Fig. 2, B and C). These results suggest that modulation of LPS-induced TLR2 upregulation by hemorrhagic shock occurs through a TLR4-dependent mechanism.

Shock-activated PMN contribute to shock-enhanced TLR2 upregulation in AM{phi}. We have previously shown that PMN and PMN-derived oxidants play an important role in mediating the upregulation of TLR2 in lung endothelial cells induced by TLR4 signaling (10). In this study, we hypothesized that PMN initially sequestered into alveoli after shock and LPS stimulation would contribute to the augmented TLR4-induced TLR2 expression in AM{phi} through PMN-AM{phi} interaction. We used the PMN-AM{phi} coculture system to test the hypothesis. AM{phi} from WT mice were cocultured with PMN that were isolated from either sham-operated or shock-resuscitated WT mice in the presence or absence of LPS for up to 6 h. The alterations in TLR2 mRNA and protein expression in the AM{phi} are shown in Fig. 3, A and B. Constitutive expression of TLR2 in the AM{phi} could be detected in the absence of LPS treatment (time 0), and this expression was unaltered when the AM{phi} were cocultured with PMN derived from mice subjected to either sham or shock (lanes 1–3). Coculture of AM{phi} with PMN derived from mice subjected to hemorrhagic shock caused a significantly higher level of TLR2 expression in the AM{phi} in response to LPS at the 6-h time point (lane 10) compared with the group cocultured with PMN isolated from sham animals (lane 9). These results suggest a dominant role of shock-activated PMN in the response.


Figure 3
View larger version (39K):
[in this window]
[in a new window]
  		Fig. 3. In vitro studies show augmented LPS-induced TLR2 expression in AM{phi} requires shock-activated neutrophils (PMN) and oxidants. PMN were isolated from blood of WT mice subjected to either sham operation or shock/resuscitation, cocultured with AM{phi} that were isolated from WT normal mice BAL fluid, and incubated with repurified LPS (1 µg/ml) for 0–6 h. At the end of incubation with LPS, AM{phi} were recovered for RT-PCR analysis (A) as well as Western blotting with anti-TLR2 antibody (B). To address the role of oxidants derived from shock-activated PMN in LPS-induced TLR2 expression in AM{phi}, membrane-permeable polyethylene glycol (PEG)-catalase (1,000 U/ml) was applied to the coculture system. Images are representative of 3 independent studies. The graphs depict means and SE of normalized densitometry of TLR2 mRNA and TLR2 protein, respectively, from 3 mice. *P < 0.01 compared between the groups as indicated.

 
To address the role of PMN-derived oxidants in signaling LPS-induced TLR2 expression in AM{phi}, antioxidant membrane-permeable polyethylene glycol (PEG)-catalase (1,000 U/ml) was applied to the coculture system. As shown in Fig. 3, A and B, PEG-catalase attenuated the effect of shock-activated PMN in increasing TLR2 expression in LPS-stimulated AM{phi}. Because the coculture experiments were performed using the Transwell approach, the results suggested that the interaction between AM{phi} and PMN might not be through a direct coupling.

To confirm the role of PMN, we next evaluated the response to shock/LPS challenge in AM{phi} of WT mice after the depletion of circulating PMN. In some cases, we replenished the PMN in the mice made neutropenic, to address the causal role of PMN in mediating the response. As shown in Fig. 4A, at 4 h after LPS challenge, neutropenia induced in mice subject to hemorrhagic shock was associated with a ~58% reduction in TLR2 expression in AM{phi} (lane 6) compared with mice subjected to shock/LPS with no PMN depletion (lane 5). In contrast, depletion of PMN did not alter TLR2 expression in sham/LPS-treated AM{phi} (lane 2). Repletion with WT PMN isolated from animals subjected to hemorrhagic shock restored the expression of TLR2 in AM{phi} in response to shock/LPS (lane 9). However, repletion with PMN derived from sham-operated animals failed to restore TLR2 expression (lane 7). Interestingly, replenishing the neutropenic sham/LPS mice with PMN that were obtained from mice subjected to hemorrhagic shock resulted in a ~3.3-fold increase in TLR2 expression in AM{phi} (lane 4) compared with non-neutropenic sham/LPS mice (lane 1). Together, these results demonstrate the critical role of shock-activated PMN in the augmented TLR4-induced TLR2 expression in AM{phi}. The changes in protein level of TLR2 shown in Fig. 4B paralleled the changes in mRNA (Fig. 4A).


Figure 4
View larger version (36K):
[in this window]
[in a new window]
  		Fig. 4. In vivo studies show hemorrhagic shock-activated PMN signal LPS-induced TLR2 expression in AM{phi}. A: RT-PCR shows the effect of PMN depletion and repletion on the expression of TLR2 mRNA in AM{phi} that were recovered from WT mice subjected to shock or sham operation 4 h after intratracheal LPS. PMN depletion was performed as described in MATERIALS AND METHODS 16 h before hemorrhage or sham operation. PMN repletion was performed in neutropenic mice using tail vein injection of PMN that were isolated from blood of WT or C3H/HeJ (C3H) mice subjected to sham or shock (at 2 h after resuscitation). The graph depicts the means and SE of normalized densitometry of TLR2 mRNA from 3 mice. *P < 0.01 compared with the control group (lane 1). B: Western blot for TLR2 protein in the AM{phi} derived from the animals treated as described in A. The graph shows the means and SE from 3 mice. *P < 0.01 compared with the control group (lane 1).

 
To further address the role of TLR4 in PMN activation, we replenished neutropenic shock/LPS WT mice with C3H/HeJ PMN. As shown in Fig. 4, A and B, PMN collected from C3H/HeJ mice subjected to either sham or shock failed to restore TLR2 expression in mice subjected to shock/LPS (lanes 8 and 10), suggesting an important role for TLR4 in the activation of PMN by shock/LPS.

Increased TLR2 expression in AM{phi} results in enhanced cytokine expression and PMN migration. To address the effect of shock-enhanced LPS/TLR4 activation of TLR2 in AM{phi} on inflammatory cytokines, we assessed MIP-2, MIF, and TNF expression in AM{phi} using sequential challenges of LPS and PGN, a ligand for TLR2. In the AM{phi}-PMN coculture system, LPS was added to the cocultures at time 0, followed by removal of the PMN and addition of PGN to the AM{phi} at 2 h (the time point at which TLR2 was upregulated in the AM{phi} as described above). MIP-2, MIF, and TNF protein levels in the AM{phi} were then assessed at 4 h by Western blotting. PMN-derived cytokines were excluded by removing PMN from the system before addition of PGN. LPS or PGN alone induced a slight increase in MIP-2, MIF, and TNF in AM{phi} that were preincubated with PMN isolated from the mice subjected to either sham or shock (Fig. 5, A–C). Whereas the sequential challenges of LPS and PGN caused small increases in the expression of inflammatory cytokines in AM{phi} that were preincubated with PMN isolated from sham-operated animals, AM{phi} that were preincubated with shock-activated PMN exhibited marked increases in MIP-2, MIF, and TNF expression in response to the sequential challenges of LPS and PGN (Fig. 5, A–C). These results suggest a priming role vis-à-vis cytokine expression of the upregulated TLR2 in enhancing AM{phi} response to bacterial components.


Figure 5
View larger version (40K):
[in this window]
[in a new window]
  		Fig. 5. Increased TLR2 expression results in augmented macrophage inflammatory protein (MIP)-2 (A), migration inhibitory factor (MIF) (B), and TNF (C) expression in AM{phi} in response to peptidoglycan (PGN). PMN were isolated from blood of WT mice subjected to either hemorrhage/resuscitation or sham operation; AM{phi} were recovered from WT normal mice BAL fluid. The cocultures were then stimulated with repurified LPS (1 µg/ml) for 2 h in DMEM containing 10% FCS at a concentration of 1 x 106 cells/ml of medium. The PMN were then removed from the cocultures, and PGN (1 µg/ml) was added to the AM{phi}. Two hours after PGN stimulation, MIP-2, MIF, and TNF-{alpha} expression in the AM{phi} lysates was detected by Western blotting. Data are representative of 4 independent studies.

 
To establish a linkage between the increased expression of the cytokines in AM{phi} and PMN migration, we recovered AM{phi} from the AM{phi}-PMN coculture system in which the AM{phi} were preincubated with shock-activated PMN and sequentially stimulated with LPS and PGN, and we injected the AM{phi} into the mouse air pouch to induce PMN migration. PMN counts in the air pouch lavage fluid at 4 h after the injection of AM{phi} are shown in Fig. 6A. AM{phi} that were preincubated with shock-activated PMN and challenged with LPS and PGN induced a significantly higher number of air pouch PMN, which was 2.7- and 2.4-fold greater than that in the groups preincubated with no PMN or the PMN isolated from sham-operated mice, respectively. These data paralleled with the changes in MIP-2, MIF, and TNF expression in the AM{phi} as shown in Fig. 5.


Figure 6
View larger version (16K):
[in this window]
[in a new window]
  		Fig. 6. Effects of combined challenges of LPS and PGN on AM{phi}-induced PMN migration. A: data obtained using in vivo air pouch model in which activated AM{phi} were used to induce migration of PMN in WT mice. The AM{phi} were isolated from WT normal mice BAL fluid, preincubated with PMN, and sequentially treated with LPS and PGN as described in Fig. 5. The AM{phi} were then injected into the mouse dorsal air pouch at a concentration of 1 x 106 cells/ml. Four hours after the injection of AM{phi}, air pouch lavage was performed, and PMN in the lavage fluid were counted. AM{phi} that were preincubated with shock-activated PMN and sequentially challenged with LPS and PGN induced a significantly higher number of air pouch PMN, which was 2.7-fold greater than that in the group preincubated with no PMN, and 2.4-fold greater than that in the group preincubated with PMN isolated from sham animals, respectively. *P < 0.01 compared with all other groups (n = 3 per group). B: to address the role of TLR2 in regulating transalveolar PMN migration in the lung, WT mice as well as C3H/HeJ (C3H) mice and TLR2–/– mice were challenged with hemorrhage/resuscitation followed by intratracheal injection of LPS (30 µg/kg body wt) plus PGN (300 µg/kg body wt) at 1 h after resuscitation. PMN in BAL fluid were counted at 2 h (open bars) and 6 h (filled bars) after LPS/PGN administration. The combination of LPS and PGN induced a 5.2-fold further increase in BAL PMN at 6 h in WT shocked mice compared with that in the 2-h group (group 8), but only induced a 2.0-fold further increase in TLR2–/– mice at 6 h (group 10). The greater difference in BAL PMN between the 6- and 2-h time points in the WT shock/LPS/PGN-treated animals indicates an enhanced PMN transalveolar migration in the lung after the primary PMN infiltration. **P < 0.01 compared with all other groups; *P < 0.01 compared with the groups with no asterisk; n = 3/group.

 
As chemokine-dependent PMN migration is an important determinant of lung PMN infiltration, we next addressed the role of shock-enhanced LPS upregulation of TLR2 in the formation of alveolar neutrophilia using the in vivo hemorrhage-resuscitation model in WT, C3H/HeJ, and TLR2–/– mice. We first challenged the mice with hemorrhage/resuscitation, and 1 h after resuscitation, we administered LPS plus PGN intratracheally. We counted PMN in BAL at 2- and 6-h points after LPS/PGN administration to represent PMN infiltration at the initial phase and later phase, respectively. As shown in Fig. 6B, at the 2-h time point, either LPS alone or LPS/PGN caused an ~8.3-fold increase in BAL PMN in WT sham-operated animals (groups 2 and 4) compared with SAL control (group 1). In contrast, LPS alone and LPS/PGN caused a 31.2- and 30.0-fold increase in alveolar PMN in WT mice subjected to shock (groups 6 and 8) compared with saline control (group 5), respectively. PGN alone caused a 4.1- and an 11.5-fold increase in BAL PMN in animals subjected to sham operation (group 3) and shock (group 7) at 2 h compared with SAL controls (groups 1 and 5), respectively. At the 6-h time point, PGN alone did not alter BAL PMN in either sham-operated or shocked animals (groups 3 and 7). In contrast, LPS alone caused a significant further increase in BAL PMN at 6 h in both sham-operated and shocked mice compared with that observed at 2 h (groups 2 and 6). However, whereas LPS/PGN caused a 2.8-fold further increase in BAL PMN in WT animals subjected to sham operation at 6 h (group 4), the treatment of LPS/PGN induced a 5.2-fold further increase in BAL PMN in WT mice subjected to shock at 6 h compared with the 2-h point (group 8), but LPS/PGN only caused a 2.0-fold further increase in TLR2–/– mice (group 10). In C3H/HeJ shocked mice, BAL PMN levels at 2 and 6 h were markedly attenuated in response to LPS/PGN challenge (group 9) compared with WT shocked mice.


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Recent studies have supported a two-hit hypothesis in the pathogenesis of lung injury in trauma patients, namely that an initial stimulus may prime for subsequent organ damage in response to a second, often minor, insult (12, 14, 27). One possible mechanism underlying this phenomenon may be that circulating PMN are primed for increased lung sequestration and cytotoxic activity (5). PMN sequestration in the lung is a result of a cascade of cellular events in which PMN, endothelia, epithelia, and AM{phi} act in concert. The role of AM{phi} in the regulation of PMN sequestration is thought to be critical, since AM{phi} initiate PMN migration through direct interactions with PMN mediated by the expression of chemokines and cytokines. We have previously reported that priming of AM{phi} after hemorrhage and resuscitation contributes to augmented lung injury, through increased release of chemokines and proinflammatory cytokines, and subsequent PMN sequestration (12, 14). However, questions remain regarding how AM{phi} are primed and whether or not interactions between PMN and AM{phi} can contribute to, and thus prime, AM{phi} for amplified pulmonary inflammation in response to a trivial infection. In the present study, we observed that LPS/TLR4 signaling upregulated TLR2 expression in AM{phi}, and shock-activated PMN played a critical role in the mechanism of TLR2 upregulation. This cross talk between TLR4 and TLR2 in AM{phi} resulted in the amplification of expression of cytokines and chemokines in response to the bacterial products LPS and PGN and subsequently led to enhanced PMN sequestration in the lung. Thus the present study demonstrates a novel mechanism underlying hemorrhagic shock-primed lung injury, namely that hemorrhagic shock-activated PMN that were initially sequestered in alveoli can instruct AM{phi} to upregulate TLR2, thereby sensitizing AM{phi} to TLR2 ligands and promoting enhanced lung inflammation (Fig. 7).


Figure 7
View larger version (41K):
[in this window]
[in a new window]
  		Fig. 7. Model of shock-activated PMN in mediating the TLR4-TLR2 cross talk in AM{phi} and AM{phi} priming. Hemorrhagic shock-activated PMN primarily migrate into alveoli in response to a trivial inflammatory stimulus, such as LPS, and interact with AM{phi}. The interaction between PMN and AM{phi} enhances LPS-induced TLR2 expression (+) in the AM{phi}, possibly mediated by PMN-derived oxidants and augmented NF-{kappa}B activation. The increased TLR2 expression results in the amplified response of the AM{phi} to TLR2 agonist (PGN), thereby augmenting cytokine and chemokine expression (circled +) and promoting enhanced PMN transalveolar migration. Thus the shock-activated PMN-mediated TLR4-TLR2 cross talk activates a positive-feedback signal leading to AM{phi} priming and exaggerated lung inflammation in response to invading pathogens. ROS, reactive oxygen species.

 
The role of TLR4 signaling in regulating TLR2 expression was clearly delineated in the studies using C3H/HeJ mice as shown in Fig. 1. This result is consistent with previous reports showing that LPS, through TLR4, upregulates TLR2 expression in macrophages (23, 28). However, we further observed that TLR4 signaling is also required for the shock-enhanced TLR2 expression, since LPS challenge of C3H/HeJ mice failed to induce enhanced TLR2 expression in a setting of hemorrhage/resuscitation. Since we used repurified LPS in all experiments to eliminate any possible effects of non-LPS contaminations, the observed TLR2 upregulation was secondary to the activation of TLR4 signaling rather than the direct LPS activation of TLR2. In in vitro studies, we found a reduced expression of TLR2 in AM{phi} in which NF-{kappa}B was inhibited by IKK-NBD, indicating a role of NF-{kappa}B in mediating the TLR4-TLR2 cross talk. However, since the inhibitory effect of IKK-NBD seemed partial, the role of other transcript factors, such as CCAAT/enhancer-binding protein, cAMP response element binding protein, and signal transducers and activators of transcription (28) may need to be investigated.

Our previous study demonstrated that antecedent shock prevents the LPS-induced reduction in TLR4 expression, thereby breaking the negative feedback mechanism of TLR4 regulation in response to LPS (13). This might be one of the mechanisms underlying cell priming for increased susceptibility to LPS after resuscitated hemorrhagic shock. However, in clinical scenarios, a variety of pathogens are involved in posttrauma lung infection. TLR2 is capable of recognizing a much broader range of pathogen components than TLR4 can. For example, TLR2 can recognize the components derived from gram-positive and gram-negative bacteria, mycobacteria, mycoplasma, and fungi (7, 16, 19, 22, 25, 30, 34, 35). Thus upregulated TLR2 may contribute to increased response in the lung to a variety of pathogens after trauma. In the present study, we showed that upregulation of TLR2 significantly amplified chemokine and cytokine expression in AM{phi} in response to PGN and functionally enhanced PMN migration. Thus the present study suggests an important physiological significance of the TLR4-TLR2 cross talk in activating a positive-feedback signal leading to amplified AM{phi} activation and local inflammation in response to invading pathogens.

Amplified AM{phi} activation and PMN infiltration induced by PGN are dependent on augmented upregulation of TLR2 that resulted from the interaction of PMN and AM{phi}. The primarily sequestered PMN seem to be important in priming for consequent enhanced PMN infiltration. This is evident by the BAL PMN counts in in vivo hemorrhage-resuscitation model as shown in Fig. 6B. In the early phase, PMN infiltration is dependent on TLR4 signaling, since BAL PMN increased at the 2-h time point in WT and TLR2–/– mice, but not in TLR4 mutant mice, in response to the treatment of shock/LPS/PGN. LPS alone increased the BAL PMN counts, whereas PGN alone did not. However, in the later phase (by 6 h), the amplified PMN infiltration is secondary to upregulated TLR2 expression as evident by the facts that 1) BAL PMN was markedly elevated in WT animals, but not in TLR2-deficient or TLR4 mutant animals, which were subjected to shock/LPS/PGN challenges; 2) either LPS or PGN alone failed to induce an amplified PMN infiltration in WT shocked mice; and 3) LPS plus PGN failed to increase the PMN counts in WT sham-operated animals. Thus the findings explored an important role of the shock-activated PMN and TLR4 signaling in activating a positive-feedback signal leading to exaggerated lung inflammation through the upregulation of TLR2 expression in AM{phi} (Fig. 7).

TLR4 per se seems play a role in shock activation of PMN as shown in Fig. 4. Repletion of neutropenic WT shocked animals with PMN derived from C3H/HeJ shocked mice did not restore AM{phi} expression of TLR2 in response to LPS. One possible mechanism underlying this phenomenon may be that shock activates PMN through releasing endogenous "danger signals" (24) and activating TLR4. Recent studies have shown that endogenous danger molecules, such as high mobility group box 1 protein (HMGB1), are potent activators of TLR4 (31). HMGB1 expression, for example, in the lung increased within 4 h after hemorrhage and is believed to contribute to the development of posthemorrhage acute lung injury (21). Another plausible explanation is that other than TLR4 playing a role in activating PMN by shock, TLR4 is also required as an LPS receptor to "fully" activate PMN in response to the following LPS challenge. However, for the PMN activation, the role of TLR4 in mediating shock-derived signals seems more important than that in mediating LPS signal, since repletion of neutropenic shocked animals with PMN from WT sham-operated mice, which possess functional TLR4, was not able to restore TLR2 expression in AM{phi}. Further investigation is required to define the precise nature of TLR4-dependent activation of PMN by shock.

Oxidants appear to participate in the regulation of TLR2 gene expression as demonstrated in Fig. 3. The most probable explanation is that oxidants enhance signaling through the TLR4-NF-{kappa}B cascade and thus promote augmented LPS-induced TLR2 gene transcription. Evidence supporting an oxidant effect on this signaling pathway is derived from two observations made in our prior reports (12, 14). First, in animal experiments, antioxidant N-acetylcysteine (NAC) addition during resuscitation prevented the augmented NF-{kappa}B translocation in AM{phi} after LPS treatment. Second, NAC supplementation reversed the enhanced LPS-induced gene transcription of the NF-{kappa}B-dependent genes, such as CINC and TNF, in AM{phi} from the animals exposed to antecedent shock. It was found in our previous studies that PMN NAD(P)H oxidase served as an important source of oxidants for mediating PMN-endothelial cell cross talk (10, 11). Further studies are required to define the source(s) of oxidants released from shock-activated PMN.

In summary, the present study demonstrates a function of shock-activated PMN in mediating TLR4-TLR2 cross talk in AM{phi} and AM{phi} priming, which acts in a positive-feedback manner to amplify pulmonary neutropenia and inflammation.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by a research grant from the Department of Surgery, University of Pittsburgh, and National Heart, Lung, and Blood Institute Grant HL-079669.


   FOOTNOTES
 

Address for reprint requests and other correspondence: J. Fan, Dept. of Surgery, CHERP Bldg. 28 (151C-U), VA Pittsburgh Healthcare System, Univ. Drive C, Pittsburgh, PA 15240 (e-mail: jif7{at}pitt.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Assier E, Jullien V, Lefort J, Moreau JL, Di Santo JP, Vargaftig BB, Lapa e Silva JR, and Theze J. NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J Immunol 172: 7661–7668,2004.[Abstract/Free Full Text]
  2. Baue AE, Durham R, and Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10: 79–89,1998.[Web of Science][Medline]
  3. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257–263,2004.[CrossRef][Medline]
  4. Boiadjieva S, Hallberg C, Hogstrom M, and Busch C. Methods in laboratory investigation. Exclusion of trypan blue from microcarriers by endothelial cells: an in vitro barrier function test. Lab Invest 50: 239–246,1984.[Web of Science]
  5. Botha AJ, Moore FA, Moore EE, Kim FJ, Banerjee A, and Peterson VM. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 118: 358–364; discussion 364–355,1995.
  6. Bowie A and O'Neill LA. Oxidative stress and nuclear factor-{kappa}B activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59: 13–23,2000.[CrossRef][Web of Science][Medline]
  7. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO, Travassos LR, Smith JA, Golenbock DT, and Gazzinelli RT. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 167: 416–423,2001.[Abstract/Free Full Text]
  8. Cotter MJ, Norman KE, Hellewell PG, and Ridger VC. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am J Pathol 159: 473–481,2001.[Abstract/Free Full Text]
  9. Edwards JC, Sedgwick AD, and Willoughby DA. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol 134: 147–156,1981.[CrossRef][Web of Science][Medline]
  10. Fan J, Frey RS, and Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 112: 1234–1243,2003.[CrossRef][Web of Science][Medline]
  11. Fan J, Frey RS, Rahman A, and Malik AB. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-{alpha}-induced NF-{kappa}B activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 277: 3404–3411,2002.[Abstract/Free Full Text]
  12. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, and Rotstein OD. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol 22: 412–421,2000.[Abstract/Free Full Text]
  13. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, Frantz S, Kelly RA, Medzhitov R, and Rotstein OD. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 168: 5252–5259,2002.[Abstract/Free Full Text]
  14. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, and Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 161: 440–447,1998.[Abstract/Free Full Text]
  15. Fleming TJ, Fleming ML, and Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6–8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151: 2399–2408,1993.[Abstract]
  16. Flo TH, Halaas O, Lien E, Ryan L, Teti G, Golenbock DT, Sundan A, and Espevik T. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 164: 2064–2069,2000.[Abstract/Free Full Text]
  17. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B, Sundan A, and Espevik T. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 69: 474–481,2001.[Abstract/Free Full Text]
  18. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, and Hyers TM. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98: 593–597,1983.[Web of Science][Medline]
  19. Heine H, Kirschning CJ, Lien E, Monks BG, Rothe M, and Golenbock DT. Cutting edge: cells that carry a null allele for toll-like receptor 2 are capable of responding to endotoxin. J Immunol 162: 6971–6975,1999.[Abstract/Free Full Text]
  20. Hirschfeld M, Ma Y, Weis JH, Vogel SN, and Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618–622, 2000.[Abstract/Free Full Text]
  21. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749–3752,1999.[Abstract/Free Full Text]
  22. Kim JY, Park JS, Strassheim D, Douglas I, Diaz Del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, and Abraham E. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288: L958–L965,2005.[Abstract/Free Full Text]
  23. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, and Golenbock DT. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274: 33419–33425,1999.[Abstract/Free Full Text]
  24. Matsuguchi T, Musikacharoen T, Ogawa T, and Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165: 5767–5772,2000.[Abstract/Free Full Text]
  25. Matzinger P. The danger model: a renewed sense of self. Science 296: 301–305,2002.[Abstract/Free Full Text]
  26. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, and Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163: 3920–3927,1999.[Abstract/Free Full Text]
  27. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135–145,2001.[CrossRef][Medline]
  28. Moore FA and Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75: 257–277,1995.[Web of Science][Medline]
  29. Musikacharoen T, Matsuguchi T, Kikuchi T, and Yoshikai Y. NF-{kappa}B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J Immunol 166: 4516–4524,2001.[Abstract/Free Full Text]
  30. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, and Mantovani A. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164: 5998–6004,2000.[Abstract/Free Full Text]
  31. Opitz B, Schroder NW, Spreitzer I, Michelsen KS, Kirschning CJ, Hallatschek W, Zahringer U, Hartung T, Gobel UB, and Schumann RR. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-{kappa}B translocation. J Biol Chem 276: 22041–22047,2001.[Abstract/Free Full Text]
  32. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370–7377,2004.[Abstract/Free Full Text]
  33. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088,1998.[Abstract/Free Full Text]
  34. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615–625,1999.[Abstract/Free Full Text]
  35. Schwandner R, Dziarski R, Wesche H, Rothe M, and Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406–17409,1999.[Abstract/Free Full Text]
  36. Takeuchi O, Hoshino K, and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165: 5392–5396,2000.[Abstract/Free Full Text]
  37. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, and Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811–815,1999.[CrossRef][Medline]
  38. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, and Segal DM. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166: 249–255,2001.[Abstract/Free Full Text]
  39. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, and Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284–288,1998.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Li, M. Xiang, Y. Yuan, G. Xiao, J. Zhang, Y. Jiang, Y. Vodovotz, T. R. Billiar, M. A. Wilson, and J. Fan
Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1670 - R1680.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Spiller, G. Elson, R. Ferstl, S. Dreher, T. Mueller, M. Freudenberg, B. Daubeuf, H. Wagner, and C. J. Kirschning
TLR4-induced IFN-{gamma} production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
J. Exp. Med., August 4, 2008; 205(8): 1747 - 1754.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/L738    most recent
00280.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, J.
Right arrow Articles by Wilson, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, J.
Right arrow Articles by Wilson, M. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.